These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28350226)

  • 1. Integration of Care in the Implementation of the Affordable Care Act: Changes in Treatment Services in a National Sample of Centers Treating Substance Use Disorders.
    Aletraris L; Roman PM; Pruett J
    J Psychoactive Drugs; 2017; 49(2):132-140. PubMed ID: 28350226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Examination of Medical Staff Utilization in Substance Use Disorder Treatment Organizations.
    Fields D; Roman P
    J Subst Abuse Treat; 2015 Dec; 59():94-8. PubMed ID: 26219681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massachusetts Substance Use Disorder Treatment Organizations' Perspectives on the Affordable Care Act: Changes in Payment, Services, and System Design.
    Quinn AE; Stewart MT; Brolin M; Horgan CM; Lane NE
    J Psychoactive Drugs; 2017; 49(2):151-159. PubMed ID: 28350232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform.
    Andrews C; Abraham A; Grogan CM; Pollack HA; Bersamira C; Humphreys K; Friedmann P
    Health Aff (Millwood); 2015 May; 34(5):828-35. PubMed ID: 25941285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act.
    Buck JA
    Health Aff (Millwood); 2011 Aug; 30(8):1402-10. PubMed ID: 21821557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Affordable Care Act and integrated care.
    Kuramoto F
    J Soc Work Disabil Rehabil; 2014; 13(1-2):44-86. PubMed ID: 24329106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico.
    Leff JA; Hernández D; Teixeira PA; Castellón PC; Feaster DJ; Rodriguez AE; Santana-Bagur JL; De León SM; Vidot JV; Metsch LR; Schackman BR
    BMC Health Serv Res; 2017 Mar; 17(1):232. PubMed ID: 28335754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence.
    Knudsen HK; Lofwall MR; Havens JR; Walsh SL
    Drug Alcohol Depend; 2015 Dec; 157():36-43. PubMed ID: 26483356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.
    Abraham AJ; Knudsen HK; Rieckmann T; Roman PM
    J Stud Alcohol Drugs; 2013 Mar; 74(2):258-65. PubMed ID: 23384373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medicalization of addiction treatment professionals.
    Roy AK; Miller MM
    J Psychoactive Drugs; 2012; 44(2):107-18. PubMed ID: 22880538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use disorder patient privacy and comprehensive care in integrated health care settings.
    Schaper E; Padwa H; Urada D; Shoptaw S
    Psychol Serv; 2016 Feb; 13(1):105-9. PubMed ID: 26845493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Diversification as A Management Strategy in Substance Use Disorder Treatment Organizations.
    Fields D; Riesenmy K; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():63-9. PubMed ID: 26021404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017.
    Parcesepe AM; Lancaster K; Edelman EJ; DeBoni R; Ross J; Atwoli L; Tlali M; Althoff K; Tine J; Duda SN; Wester CW; Nash D;
    PLoS One; 2020; 15(8):e0237772. PubMed ID: 32853246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of perceived need and health insurance in substance use treatment: implications for the Affordable Care Act.
    Ali MM; Teich JL; Mutter R
    J Subst Abuse Treat; 2015 Jul; 54():14-20. PubMed ID: 25753655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers.
    Knudsen HK; Studts JL
    J Psychoactive Drugs; 2017; 49(2):111-121. PubMed ID: 28296579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoption and implementation of new technologies in substance abuse treatment.
    Roman PM; Johnson JA
    J Subst Abuse Treat; 2002 Jun; 22(4):211-8. PubMed ID: 12072165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Massachusetts Health Care Reform Impact on Fee-for-Service-Funded Substance Use Disorder Treatment Providers.
    Fields D; Pruett J; Roman PM
    J Psychoactive Drugs; 2015; 47(5):417-25. PubMed ID: 26514378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Patients' Preference for Integrated Models of Addiction and HIV Treatment in Vietnam.
    Nguyen Bich D; Korthuis PT; Nguyen Thu T; Van Dinh H; Le Minh G
    J Subst Abuse Treat; 2016 Oct; 69():57-63. PubMed ID: 27568511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act.
    Ghitza UE; Tai B
    J Health Care Poor Underserved; 2014 Feb; 25(1 Suppl):36-45. PubMed ID: 24583486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.